Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating Ca2+ release deficiency syndrome in human iPSC-derived cardiomyocytes

EF 2021-22

Résumé
Some heartbeat rhythm disorders (i.e. arrhythmias), such as catecholaminergic polymorphic ventricular tachycardia (CPVT), have a high risk of leading to a sudden stop in electrical heart activity (i.e. sudden cardiac arrest). Most CPVT cases result from inherited mutations in a large protein needed for normal electrical signals in heart cells known as the cardiac ryanodine receptor (RyR2). In typical CPVT cases, mutations in RyR2 cause the protein to be overactive, and exercise stress testing serves as an accurate diagnostic tool in these patients. However, in cases where RyR2 mutations lead to underactivity, patients still experience arrhythmia but test negative on exercise stress testing. These cases were previously referred to as atypical CPVT. Recent studies have shown that atypical CPVT may be completely distinct from CPVT, with different cellular mechanisms by which electrical activity is disrupted. This newly identified condition is referred to as calcium release deficiency syndrome (CRDS). Importantly, there are currently no approved diagnostic tests for CRDS patients, hence patients remain at high risk for misdiagnosis and sudden cardiac arrest. To improve our understanding of CRDS, we are proposing to study a CRDS-associated RyR2 variant (I4855M) in human heart cells derived from induced pluripotent stem cells. Using various electrophysiological methods, we will identify the specific mechanism by which this mutation disrupts electrical activity in human heart cells. In addition, we will examine the biochemical changes associated with this variant to reveal its impact on RyR2 protein structure and function. In doing so, our study can help build the foundation for novel diagnostics and pharmacotherapies for precise and personalized care for CRDS patients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466658
Name
Dababneh Saif
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Ca2+ release deficiency syndrome in human iPSC-derived cardiomyocytes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmogenesis; Crds; Cryo-Em; Human Induced Pluripotent Stem Cells; Inherited Arrhythmias; Ryanodine Receptor; Sr Calcium Release; Sudden Cardiac Arrest
Abstract
Some heartbeat rhythm disorders (i.e. arrhythmias), such as catecholaminergic polymorphic ventricular tachycardia (CPVT), have a high risk of leading to a sudden stop in electrical heart activity (i.e. sudden cardiac arrest). Most CPVT cases result from inherited mutations in a large protein needed for normal electrical signals in heart cells known as the cardiac ryanodine receptor (RyR2). In typical CPVT cases, mutations in RyR2 cause the protein to be overactive, and exercise stress testing serves as an accurate diagnostic tool in these patients. However, in cases where RyR2 mutations lead to underactivity, patients still experience arrhythmia but test negative on exercise stress testing. These cases were previously referred to as atypical CPVT. Recent studies have shown that atypical CPVT may be completely distinct from CPVT, with different cellular mechanisms by which electrical activity is disrupted. This newly identified condition is referred to as calcium release deficiency syndrome (CRDS). Importantly, there are currently no approved diagnostic tests for CRDS patients, hence patients remain at high risk for misdiagnosis and sudden cardiac arrest. To improve our understanding of CRDS, we are proposing to study a CRDS-associated RyR2 variant (I4855M) in human heart cells derived from induced pluripotent stem cells. Using various electrophysiological methods, we will identify the specific mechanism by which this mutation disrupts electrical activity in human heart cells. In addition, we will examine the biochemical changes associated with this variant to reveal its impact on RyR2 protein structure and function. In doing so, our study can help build the foundation for novel diagnostics and pharmacotherapies for precise and personalized care for CRDS patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dababneh, Saif
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~